From the Daily Caller
Steve Milloy
Participant
The United States is by far the world's leading donor in biomedical research. According to reports, the Trump government is reportedly planning to ask the Congress to reduce the budget of the National Institutes of Health from $ 47 billion to $ 27 billion in order to meet the expenses for the states' expenses.
Grant recipients and their support communities in the weapons are not unexpected. They claim that the proposed cuts would withdraw the financing that they need to find remedies. They say the US will lose its global dominance in this area together with enormous profits.
But the critical questions are: “What does the research actually financed by the NIH actually indicate?” And “are the services worth the money?” The answers, at least according to Nih itself, seem to be shockingly little for the huge sums. (Related: Steve Milloy: Trump's EPA has the right to be skeptical about “sun blocking”)
On his website, Nih divides his services for 2024 under three headings: (1) “Progress of human health”; (2) “Promising medical results” and (3) “Basic research knowledge”. Five NIH-Anglagene are successful under each heading.
The first article listed under “Human Health Advances”, a category that represents the latest and largest from NIH research, is “precise blood test for Alzheimer's disease”. After listening to a left head train to the head train Trump and Elon Musk because he had attributed Alzheimer's research at the age of 20, I examined the advance of the Alzheimer's that Nih had touted Nih on his list of success.
The progress referred to a study published in the Journal of the American Medical Association in July 2024, in which he reported on a new blood test, which correctly diagnosed Alzheimer's with 1,213 Swedish Alzheimer's patients with an accuracy of 90 percent.
Although this sounds impressive, the authors of the study qualify their results with two important restrictions: (1) In other cohorts of patients, further tests were required to confirm their results; and (2) “Future studies should evaluate how the use of blood tests for these biomarkers influence clinical care.” Far from being a “advance of human health”, the researchers admitted that they still had to confirm their results and that they are not sure whether the blood test is useful, even if the results are confirmed.
Nih was only one of 20 different researchers of research. It recorded two Swedish researchers a total of 993,478 US dollars. The other 14 Swedish researchers in the study were apparently financed by the other around Swedish donors.
The study is really only remarkable because Nih anointed it as top for 2024. But what does that say about the other 36.8 billion US dollars that NiH spent on 60,000 other grants? An incompatible Alzheimer's blood examination is pride and joy under all this financing?
A recently from the Washington Post OP-ED entitled “Science needs more shrimp on treadmills” said that “the National Institutes of Health does not finance too much stupid science. It is not financed enough.” The author tried to owe Nih to the development of medication for weight reduction such as Ozempic. In 1984 a hiker -NiH researcher published a study on Gila Monster Gift. After four decades of research elsewhere, others used the finding to develop the blockbuster GLP-1 medication. In a way, this is an amazing story. On the other hand, it is not proof that NIH's enormous expenses for taxpayers achieve results.
President Nixon started the “war against cancer” in 1971, and since then, every president has tried to make a name for himself in these efforts, but the breakthroughs have limited. In 1986 the all-star biostatistic John Bailarar observed that cancer remained unbeaten. In 2018, cancer researchers in the British Medical Journal reported that the expensive medication, which were recommended by the guidelines for cancer treatments in the United States, was based on “weak evidence”. President Biden's “Cancer Moonshot” essentially produced zero.
Nih did not mention cancer progress under “Progress of Human Health” or “promising medical knowledge” for 2024. The only mention of cancer comes in “basic research knowledge” with “assigning and spreading cancer”. Fifty -four years after the start of the Cancer War, there we are.
None of this is called that Nih should not finance medical research. However, if NIH continues to spend tax money, it has to make some expenses and entry of achievements. We are $ 36 trillion and cannot afford it to make designated billions of dollars for non-productive research in the hope that something will ultimately appear.
And no, there is no need to worry about foreign competition. We spend about 18 times more than Great Britain, our next competitor in relation to medical research. The rest of the world may freely ride the rest of the world on the back of the US taxpayers. It may also be that the rest of the world has recognized that there are more productive opportunities to spend your taxpayers.
Steve Milloy is a biostatistic and lawyer, publishes Junkscience.com and is on X @Junkscience.
The views and opinions in this comment are that of the author and do not reflect the official position of the Daily Caller News Foundation.
All content created by the Daily Caller News Foundation, an independent and impartial newswire service, are available without indictment for a legitimate news publisher who can offer a large audience. All published articles must include our logo, the byline of our reporter and your DCNF affiliation. If you have any questions about our guidelines or a partnership with us, please contact licensing@dailycallernewsfoundation.org.
Like this:
Load…
Related
Do you discover more from watts?
Subscribe to the latest posts to your e -mail.
